Related Experiment Video
Updated: Apr 15, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Methods for estimating kidney disease stage transition probabilities using electronic medical records
Lola Luo1, Dylan Small1, Walter F Stewart2
1University of Pennsylvania.
Understanding chronic kidney disease (CKD) progression is crucial. This study estimates CKD stage transition rates using electronic health records (EHR) and hidden Markov models (HMMs), revealing key insights into disease progression.
Area of Science:
- Biostatistics
- Epidemiology
- Nephrology
Background:
- Chronic diseases, including chronic kidney disease (CKD), are staged by severity, influencing clinical decisions.
- Estimating transition rates between CKD stages is vital for patient management but challenging due to data variability.
Purpose of the Study:
- To develop and validate a method for estimating CKD stage transition rates using electronic health records (EHR).
- To address the challenges of irregular data collection and varying observation times in EHR data.
Main Methods:
- Utilized hidden Markov models (HMMs) to estimate transition rates, accounting for varying information levels and observation times.
- Employed a discretization method to transform daily data into manageable intervals (30, 90, 180 days) for computational efficiency.
- Validated the approach through simulation studies assessing accuracy, computation time, and the impact of informative observation times and missing data.
Main Results:
- The developed HMM approach demonstrated good performance, even with non-ignorable missing data.
- Applied to over 60,000 primary care patients with CKD (stage 2+), the method estimated transition rates between six disease states.
- Estimated transition rates were found to be similar between men and women.
Conclusions:
- The study presents a robust method for estimating CKD stage transition rates from EHR data, overcoming common analytical challenges.
- The findings provide valuable quantitative insights into the dynamics of CKD progression in a large primary care population.
- This methodology can inform clinical practice and public health strategies for managing chronic kidney disease.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Chronic Kidney Disease I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

